Trulieve Cannabis Corp. (TRLV)
TRLVNYSE Medicinal Chemicals and Botanical Products
$11.05
+0.0575 (+0.52%) today
Closed, Nov 13, 4:00 PM ET
- Market cap
- $2.10bn
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- –
- 52-week range
- $7.82 to $12.93
- Average volume
- –
- Previous close
- $11.00
Analysts
6 coveringBuy6 buy, 0 hold, 0 sell
Targets a year out average $17.25, +56.1% from here
Earnings
next estimate $0.0200Next report
Jun 2026
+83.3%
Sep 2026
0.0%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $293.15m | $286.75m | $270.95m | $230.22m |
| Gross profit | $175.16m | $170.08m | $162.29m | $148.02m |
| Operating income | $15.30m | $35.73m | -$370.52m | $42.49m |
| Net income | -$42.90m | $2.41m | -$405.98m | $869.0k |
Last four quarters: revenue $1.08bn, margin -41.2%, free cash flow $188.18m
News
8 latest- Trulieve Cannabis Q3 Earnings Call HighlightsMarketBeat · 5 days ago
- Trulieve (TRLV) Q3 2026 Earnings Call TranscriptThe Motley Fool · Nov 5, 2026
- Trulieve Cannabis Corp. Reports Third Quarter 2026 Revenue of $230 millionFintel · Nov 5, 2026
- Zacks Industry Outlook Highlights ICU Medical, Neogen and Trulieve CannabisZacks · Oct 12, 2026
- 3 Medical Product Stocks Positioned to Ride on the Industry TailwindsZacks · Oct 9, 2026
- 2 High-Octane Cannabis Stocks to Buy in October for Aggressive InvestorsThe Motley Fool · Oct 3, 2026
- 2 Cannabis Stocks That Are Quietly Trouncing the Market in 2026The Motley Fool · Sep 22, 2026
- Trulieve Cannabis Q2 Earnings Call HighlightsMarketBeat · Aug 9, 2026
The company
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with established medical marijuana operations in Florida, Georgia, Pennsylvania, and West Virginia. Driven by a core mission to expand access to cannabis, Trulieve serves customers with innovative, high-quality branded products and exceptional experiences. With scaled operations in attractive markets and targeted expansion through its hub strategy, Trulieve is poised for accelerated growth.
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- Exchange
- NYSE
- Region
- North America
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.